Dr. Francisco Salcido, M.D.
What this data tells you about Dr. Salcido
Dr. Francisco Salcido is a family medicine in Odessa, TX, with 20 years in practice. Based on federal Medicare data, Dr. Salcido performed 3,194 Medicare services across 1,966 unique beneficiaries.
Between the years covered by Open Payments, Dr. Salcido received a total of $8,585 from 53 pharmaceutical and/or device companies across 538 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Salcido is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) | 491 | $56 | $184 |
| Blood draw (venipuncture) | 321 | $8 | $20 |
| Complete blood count (CBC) with differential | 263 | $7 | $41 |
| Office visit, established patient (30-39 min) | 190 | $76 | $283 |
| Manual urinalysis test with examination using microscope, non-automated | 169 | $4 | $29 |
| Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | 162 | $28 | $70 |
| Dexamethasone injection (steroid) | 156 | $0 | $10 |
| Drug injection, under skin or into muscle | 155 | $9 | $45 |
| Hemoglobin A1c test (diabetes monitoring) | 154 | $9 | $38 |
| Steroid injection (triamcinolone) | 142 | $1 | $10 |
| Detection test by immunoassay with direct visual observation for influenza virus | 119 | $16 | $56 |
| Ceftriaxone antibiotic injection | 110 | $0 | $14 |
| Automated urinalysis | 88 | $2 | $29 |
| Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | 86 | $22 | $35 |
| Flu vaccine administration | 81 | $30 | $35 |
| Blood glucose (sugar) level | 74 | $4 | $44 |
| Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | 59 | $33 | $150 |
| Office visit, established patient (10-19 min) | 57 | $32 | $110 |
| Electrocardiogram (EKG), 12-lead | 50 | $8 | $65 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 49 | $38 | $70 |
| Urine microalbumin (protein) analysis | 39 | $6 | $40 |
| Injection, ketorolac tromethamine, per 15 mg | 38 | $0 | $15 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 27 | $1 | $18 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 26 | $271 | $490 |
| Blood glucose (sugar) test performed by hand-held instrument | 25 | $3 | $23 |
| Pneumonia vaccine administration | 25 | $28 | $35 |
| Annual wellness visit, follow-up | 14 | $106 | $200 |
| Administration of vaccine | 13 | $12 | $35 |
| Chest X-ray, 2 views | 11 | $26 | $100 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 6% for family medicine in TX.
Geographic Context
5.8 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Salcido is a clinical cardiology specialist, with above-average Medicare volume (top 7% in TX), and high industry engagement (low-engagement, top 6%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Salcido experienced with office visit, established patient (20-29 min)?
Does Dr. Salcido receive payments from pharmaceutical companies?
How do Dr. Salcido's costs compare to other family medicines in Odessa?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology